Google Übersetzer
Upstream Bio, Inc.
About
8.26USD+0.05 +0.61%
Closed • Updated at 01:08 GMT+00:00Market Cap$449.51M
Volume420.4K
Beta1.61
RSI38.88
Gross Margin94.16%
Upstream Bio, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 18 2026
Upstream Bio Presents New Data from Phase 2 VIBRANT Trial of Verekitug Demonstrating Improvement in Asthma Symptom Control in Participants with CRSwNP and Comorbid Asthma at the ATS 2026 International Conference
May 13 2026
Upstream Bio Reports First Quarter 2026 Financial Results and Recent Business Highlights
Apr 17 2026
Upstream Bio to Present New Data from Phase 2 VIBRANT Trial of Verekitug at the ATS 2026 International Conference
Mar 26 2026
Upstream Bio Highlights Phase 3 Development Strategy for Verekitug and Reports Fourth Quarter and Full Year 2025 Financial Results
Mar 1 2026
Upstream Bio Presents Additional Analyses from the Phase 2 VIBRANT Trial of Verekitug in Chronic Rhinosinusitis with Nasal Polyps at 2026 AAAAI Annual Meeting
Recent Videos
Upstream Stock #13 — Harbour Energy 2026: PE 4.2x, 18% FCF Yield — Deeply Undervalued? 🛢️
May 16, 2026
Upstream Stock #04 — APA Corp | 55-Year Dividend, Permian + Suriname Upside 🛢️
May 15, 2026
Upstream Stock #02 — Equinor | 5% Dividend, Buybacks & North Sea Cashflow 🛢️
May 13, 2026
Upstream Stock #03 — OMV | European Gas Cashflow & 9%+ Dividend Power ⛽
May 13, 2026
Community Chat
Ask AI
Try asking